Bio-Nucleonics, Inc. is a privately-held Florida corporation that specializes in developing, manufacturing, and marketing generic radiopharmaceuticals, medical devices and imaging agents for the detection and treatment of oncological, cardiovascular, and neurological diseases. The Company’s business strategy is to capitalize on its proven expertise by developing a portfolio of products specifically targeted towards patient quality of life.

Our products embody features that provide clinical as well as economic benefits at a time of rapidly changing healthcare environment. We believe that inherent competitive advantages and production capabilities provide us with a sound platform for dynamic growth in large niche markets. This approach is expected to result in considerable market share gain, sustained expansion, significant revenue potential, and high profit margins.

FACILITY

Bio-Nucleonics’ facilities consist of 10,000 Sq. Ft. of state-of-the-art laboratories and Class 100 cleanrooms specially designed for the manufacture of current and future pipeline products and the development of radioactive drugs and devices. Capabilities include formulation, aseptic processing, sterilization, validation, microbiological testing and regulatory compliance. The Company’s core competencies are well demonstrated by the operation of an approved cGMP production facility in such a highly regulated environment.